Metropolis Healthcare (NSE:METROPOLIS) Common Stock: ₹0 Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:METROPOLIS Metropolis Healthcare Ltd NSE:METROPOLIS
94 GF Score
Price ₹555.00
GF Value ₹601.01
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Metropolis Healthcare Common Stock?

Metropolis Healthcare NSE:METROPOLIS +0.55% 94 Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus rates NSE:METROPOLIS with a GF Score™ of 94/100 and a GF Value™ of ₹601.01 (Fairly Valued). The stock has 4 warning signs investors should review.

Metropolis Healthcare's quarterly common stock increased from Dec. 2025 (₹0 Mil) to Mar. 2026 (₹415 Mil) but then declined from Mar. 2026 (₹415 Mil) to Jun. 2026 (₹0 Mil).

Metropolis Healthcare's annual common stock increased from Mar. 2024 (₹102 Mil) to Mar. 2025 (₹104 Mil) and increased from Mar. 2025 (₹104 Mil) to Mar. 2026 (₹415 Mil).

Metropolis Healthcare Common Stock Historical Data

* Premium members only.

The historical data trend for Metropolis Healthcare's Common Stock can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Metropolis Healthcare Common Stock Chart

Metropolis Healthcare Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Common Stock
Get a 7-Day Free Trial Premium Member Only Premium Member Only 102.34 102.42 102.45 103.60 414.66

Metropolis Healthcare Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Common Stock Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 103.62 0.00 414.66 0.00
NSE:METROPOLIS
94GF Score
Metropolis Healthcare Ltd NSE:METROPOLIS
Common Stock is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Metropolis Healthcare Common Stock Calculation

Common stock is listed on the Balance Sheet at the par value of the total shares outstanding of a company.

The par value of common stocks is meaningless. It is usually set at an absurdly low number.

Frequently Asked Questions Learn more about Common Stock →
What does a Common Stock of ₹0 Mil mean?
Metropolis Healthcare (NSE:METROPOLIS) has a Common Stock of ₹0 Mil as of Jun. 2026. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Metropolis Healthcare and its competitors.
Is Metropolis Healthcare's Common Stock too high?
Metropolis Healthcare's current Common Stock is ₹0 Mil. Overall, Metropolis Healthcare has a GF Score™ of 94/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Metropolis Healthcare's Common Stock compare to TMO and DHR?
Metropolis Healthcare's Common Stock of ₹0 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Common Stock for a Medical Diagnostics & Research company?
A good Common Stock depends on the Medical Diagnostics & Research industry context. However, Common Stock should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Common Stock mean?
A high Common Stock can signal that a stock is expensive relative to its fundamentals. Common Stock is the par value of a company's shares outstanding, as listed on the balance sheet. View historical data on Metropolis Healthcare and its competitors. Metropolis Healthcare's current Common Stock is ₹0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Metropolis Healthcare stock overvalued right now?
Based on GuruFocus' analysis, Metropolis Healthcare (NSE:METROPOLIS) is currently considered Fairly Valued. The stock's GF Value™ is ₹601.01, compared to a current price of ₹555.00 — trading 7.7% below its estimated fair value. The current Common Stock is ₹0 Mil. Metropolis Healthcare's overall GF Score™ is 94/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Common Stock calculated?
Common Stock is calculated from a company's financial statements. For Metropolis Healthcare (NSE:METROPOLIS), the current Common Stock is ₹0 Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Metropolis Healthcare (NSE:METROPOLIS) Overvalued in 2026?

Based on GuruFocus' analysis, Metropolis Healthcare stock appears to be undervalued. The current stock price of ₹555.00 is trading 7.7% below its estimated GF Value™ of ₹601.01. GuruFocus considers Metropolis Healthcare to be Fairly Valued.

Key valuation signals for NSE:METROPOLIS:

  • Common Stock: ₹0 Mil
  • GF Value™: ₹601.01 vs. price of ₹555.00 (7.7% below fair value)
  • GF Score™: 94/100 with 4 warning signs

No single metric tells the full story. See the NSE:METROPOLIS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Metropolis Healthcare Business Description

Other Exchanges 542650:India
Address Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030
Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.
94GF Score

Get the complete analysis for NSE:METROPOLIS

Common Stock is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹555.00
Price
₹601.01
GF Value